Valeant shares surge after drugmaker reports US$1.3B quarterly profit

The head office and logo of Valeant Pharmaceuticals is shown in Laval, Que., on May 27, 2013. Valeant Pharmaceuticals International Inc. reported a profit of $1.3 billion in its latest quarter, boosted by a one-time gain related to an internal tax reorganization.THE CANADIAN PRESS/Ryan Remiorz MONTREAL — Shares of Valeant Pharmaceuticals International Inc. surged more…

Details